RUSHB exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9, indicating solid operational efficiency. However, the stock is severely overvalued, trading at $74.20—well above its Graham Number ($46.02) and Intrinsic Value ($22.89). This valuation gap is exacerbated by negative YoY revenue (-11.80%) and earnings growth (-11.00%), suggesting the current price is driven by momentum rather than fundamentals. Despite strong recent price performance, the combination of a high PEG ratio (3.09) and declining growth metrics points to a significant correction risk.